Trials / Withdrawn
WithdrawnNCT00477425
A Study to Evaluate Corrected QT Interval From Clinical Studies Conducted With Bevacizumab
Evaluation of Corrected QT Interval From Clinical Studies Conducted With Bevacizumab
- Status
- Withdrawn
- Phase
- —
- Study type
- Observational
- Enrollment
- 0 (actual)
- Sponsor
- Genentech, Inc. · Industry
- Sex
- All
- Age
- —
- Healthy volunteers
- Not accepted
Summary
This is a supplemental study designed to evaluate the effect of bevacizumab on QTc interval in cancer patients. Patients who have consented to participate in selected randomized controlled bevacizumab clinical trials will be invited to participate in this study.
Conditions
Timeline
- Start date
- 2007-06-01
- Primary completion
- 2007-06-01
- Completion
- 2007-06-01
- First posted
- 2007-05-23
- Last updated
- 2017-05-15
Source: ClinicalTrials.gov record NCT00477425. Inclusion in this directory is not an endorsement.